Which company benefits the most from the "Guidelines for Home Chinese Medicine Intervention for People Infected with New Coronavirus"

The Expert Committee on Traditional Chinese Medicine Disease Prevention and Control of the State Administration of Traditional Chinese Medicine issued the "Guidelines for Home-based Traditional Chinese Medicine Intervention for Patients Infected with New Coronavirus". In terms of adult treatment options, Shufeng Jiedu Capsules (granules), Jingfang Baidu Granules, Qingfei Paidu Granules, Sanhan Huashi Granules, Ganmao Qingre Capsules (granules), Jingfang Granules, Zhengchaihuyin Granules, Jiuwei Traditional Chinese medicines such as Qianghuo Pills (granules), Sijiganmao Tablets, Ganmao Shufeng Capsules (tablets, granules) are included in the guidelines.

After the announcement of the Ten New Regulations on Epidemic Prevention, residents from all over the country started a craze to build “home anti-virus medicine kits”. Even Lianhua Qingwen’s search volume increased 2,000 times year-on-year. Which other drugs are as worthy of attention as Lianhua Qingwen? Which listed companies manufacture these drugs? This article will sort it out in detail.

Reference list of commonly used drugs for home treatment of patients with new coronavirus infection

Source: State Council Comprehensive Team of Joint Prevention and Control Mechanism for New Coronavirus Pneumonia Epidemic

Lian Huaqing Search volume increased by 2,000 times year-on-year. Affected by the adjustment of epidemic prevention and control measures in many places, JD Health’s sales of cold medicines, antipyretic, cough relieving, antibacterial and anti-inflammatory drugs have increased significantly. JD Health data shows that the transaction volume of the above-mentioned drugs in the past seven days has increased 18 times compared with October. The top 5 drugs in terms of number of transactions are Lianhua Qingwen, Pudilan Anti-inflammatory Tablets, Compound Paracetamol Alkamine Tablets, Ibuprofen Sustained Release Capsules, and Paracetamol. Aminophenol; among them, the search volume of Lianhua Qingwen increased 2,000 times year-on-year.

A number of traditional Chinese medicine prescriptions or proprietary Chinese medicines have been included in the new coronavirus diagnosis and treatment guidelines. According to the "New Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial Ninth Edition Revision)" released in March 2022, multiple prescriptions or Chinese patent medicines have been included. Based on the clinical effects, the "three prescriptions and three medicines" were selected, namely Jinhua Qinggan Granules, Lianhua Qingwen Capsules, Xuebijing Injection, as well as Qingfei Paidu Decoction, Huashibaidu Recipe, and Xuanfei Baidu Recipe. Among them, Qingfei Paidu Recipe The corresponding Chinese patent medicines of Paidu Granules, Xuanfei Baidu Recipe, and Huashi Baidu Recipe will be quickly approved in 2021 according to the new 3.2 category of traditional Chinese medicines.

Recommendations for the use of traditional Chinese medicines in the ninth edition of the COVID-19 Diagnosis and Treatment Plan

Source: National Health Commission, State Administration of Traditional Chinese Medicine

Top-level design blessing, China Pharmaceutical development has become a national strategic and long-term issue. The "Opinions on Promoting the Inheritance and Innovative Development of Traditional Chinese Medicine", the "Guiding Opinions on Medical Insurance Supporting the Inheritance and Innovative Development of Traditional Chinese Medicine" and the "14th Five-Year Plan for the Development of Traditional Chinese Medicine" issued from 2019 to 2022 have repeatedly reiterated the importance of inheritance and innovative development. importance and role in disease prevention, and proposes to establish and improve a mechanism for traditional Chinese medicine expenses that comply with epidemic diagnosis and treatment standards to be included in the scope of medical insurance payment according to regulations. The top-level design fully supports the innovative development of traditional Chinese medicine on the basis of inheriting the precious wealth of our ancestors. The development of traditional Chinese medicine has become a national strategic and long-term issue.

Top-level design supports relevant policies for the traditional Chinese medicine industry

Source: State Food and Drug Administration, Chinese Government Website

The important role of traditional Chinese medicine in epidemic prevention and control Widely tested and approved. The "Opinions on Promoting the Inheritance and Innovative Development of Traditional Chinese Medicine", the "Guiding Opinions on Medical Insurance Supporting the Inheritance and Innovative Development of Traditional Chinese Medicine" and the "14th Five-Year Plan for the Development of Traditional Chinese Medicine" issued from the end of last year to the beginning of this year all positively affirmed traditional Chinese medicine. Fully participating in prevention, control and treatment, it has played an important role in the fight against the new coronavirus epidemic. Many provinces and places have successively issued TCM prevention and treatment guidelines, diagnosis and treatment plans, and recommended medications. In the process of preventing and controlling the Omikron epidemic , traditional Chinese medicine has been deeply involved in all key areas and achieved outstanding results.

Related listed companies sorted out

Zhenbaodao: According to December 10, the State Administration of Traditional Chinese Medicine Expert Committee on Traditional Chinese Medicine Disease Prevention and Control issued the "Guidelines for Home Traditional Chinese Medicine Intervention for People Infected with New Coronavirus". Zhenbaodao Pharmaceutical's Compound Qinlan Oral Liquid, Shuanghuanglian Oral Liquid, Shengmai Yin, and Pediatric Cough Syrup are included in the recommended medications.

Guizhou Bailing: The company's exclusive Miao medicine "Kesu Stop Syrup", exclusive brand "Xiao'er Chai Gui Antipyretic Granules" and Xiao Bupleurum Granules were selected and listed as recommended drugs for the treatment of adults and children respectively.

Lei Yunshang Liushen Pills (capsules) have also entered the "Guidelines for Home Chinese Medicine Intervention for Patients Infected with New Coronavirus".

Kangyuan Pharmaceutical: The company's Sanhan Huashi Granules will be sold successively in Kangyuan Pharmaceutical flagship stores on JD.com and Tmall from November 24th and 25th. In response to questions from investors, it was stated that the company's overall production capacity can meet the current sales demand for cold-dispersing and humidifying granules. At the same time, the company is also expanding production capacity through technical transformation and other measures to ensure that it meets future market demand.

Yisheng Pharmaceutical: The company’s Qingkailing Injection, Shengmai Injection and Ginseng have been included in the diagnosis and treatment plan for new coronavirus pneumonia many times.

Hongri Pharmaceutical: The company's product Xuebijing Injection has been continuously included in the "New Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial Fourth Edition - Ninth Edition)", and has been recommended by the State Administration of Traditional Chinese Medicine to be included in the anti- The "three medicines and three prescriptions" of traditional Chinese medicine for epidemic diseases.

Xiangxue Pharmaceutical: The company’s Yuekang No. 1 traditional Chinese medicine decoction has been included in the “Guangdong Province Traditional Chinese Medicine Intervention Plan for Close Contacts of Novel Coronavirus Pneumonia”.

Huoxiang Zhengqi oral liquid (water, pills, tablets, capsules, granules, soft capsules): Yunnan Baiyao, Pien Tze Huang, Guang Yuyuan, Tiansheng Pharmaceutical, Taiji Group, Buchang Pharmaceutical, etc.;

p>

Antiviral granules (oral liquid): Wohua Pharmaceutical, Kangyuan Pharmaceutical, Xiangxue Pharmaceutical, etc.;

Shuangqing mixture: Lisheng Pharmaceutical;

Jinhua Qinggan Granules: Tasly, etc.;

Lianhua Qingwen Capsules (granules): Yiling Pharmaceutical;

Fangfeng Tongsheng Pills (granules): Tong Ren Tang, Foci Pharmaceutical, Jingxin Pharmaceutical Industry, China Resources Sanjiu, Dong'e Ejiao, Qianjin Pharmaceutical, Sunway Pharmaceutical, Sunflower Pharmaceutical, Datang Pharmaceutical, Guangyuyuan, Zhendong Pharmaceutical, Wohua Pharmaceutical, Enwei Pharmaceutical, etc.;

Jiuwei Qianghuo granules (pills): Sunflower Pharmaceutical, Jiuzhitang, Foci Pharmaceutical, etc.;

Qingfei Xiaoyan Pills: Zhongxin Pharmaceutical;

Reduning Injection: Kangyuan Medicine Industry;

Xuebijing Injection: Hongri Pharmaceutical;

Xingnaojing Injection: Dali Pharmaceutical;

Angong Niuhuang Pill: Bu Chang Pharmaceutical, Baiyunshan, Tasly, Taiji Group, Pien Tze Huang, Jiuzhitang, Panlong Pharmaceutical, Jingxin Pharmaceutical, Guangyuyuan;

Suhexiang Pills: Tongrentang, Jiuzhitang, Foci Pharmaceutical, etc.;

p>

Shenmai Injection: China Resources Sanjiu, Shenwei Pharmaceutical, Dali Pharmaceutical, etc.;

Shengmai Injection: Yisheng Pharmaceutical, China Resources Sanjiu, etc.;

Shenfu Injection: China Resources Sanjiu, etc.;